非常规 T 细胞在泌尿系统肿瘤中：能抓住就抓住

Unconventional T cells in urological cancers: catch them if you can.

BCG 激活的白细胞足以产生不依赖于供体的先天性抗肿瘤 NK 和γδ T 细胞，这些细胞可在体外进一步扩增

BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in

γδ T 细胞在膀胱癌 BCG 治疗期间支持抗原特异性 αβ T 细胞介导的抗肿瘤反应

γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder Cancer.

构建基因-代谢物-微生物组调控网络，通过多组学分析揭示膀胱癌的新治疗靶点

Construction of a gene-metabolite-microbiome regulatory network reveals novel therapeutic targets in bladder cancer through multi-omics analysis.

这项综合多组学分析将关键基因、代谢物和微生物与 BLCA 发病机制联系起来。成纤维细胞成为核心调节因子，而所识别的基因-代谢物相互作用和微生物关联为肿瘤异质性提供了新见解。这些发现突出了潜在生物标志物和治疗靶点，以支持 BLCA 的精准治疗。

功能性抗氧化剂对γδ T 细胞扩增及其对膀胱癌细胞细胞毒性的影响

Effects of functional antioxidants on the expansion of gamma delta T-cells and their cellular cytotoxicity against bladder cancer cells.

牛型分枝杆菌卡介苗（BCG）在肿瘤治疗中的作用：膀胱癌及其他领域

Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond.

单次 BCG 脉冲后长期培养中抗肿瘤固有淋巴细胞的选择性扩增

Selective expansion of anti-tumor innate lymphocytes in long-term cultures after a single BCG pulse.